About Us

The American Society for Experimental Neurotherapeutics (ASENT) is an independent non-profit organization established in 1997 by leaders in academia, government, advocacy and industry to facilitate the process by which new therapies are made available to patients with neurological disorders. Its primary goal is to encourage and advance the development of improved therapies for diseases and disorders of the nervous system.

ASENT engages in scientific exchanges to encourage contacts between those involved in the discovery and development of neurotherapeutics and to provide opportunities for dialogue between the interested groups.  The society organizes education and training and publishes a journal for healthcare practitioners, scientists and officials participating in the neurotherapeutics field, which serves as a forum for its members and interested groups addressing diverse issues.

To advance the science of neurotherapeutics and to improve and accelerate the development of new treatments

ASENT combines academia, government, clinical community, industry and advocacy to enable and advance the discovery, translation and development of neurotherapeutics.

Drive the development of next generation therapeutics through world-class dialogue. Promote the highest scientific and ethical principles in therapeutic discovery and clinical investigation. Create a strong organization scaffold to support ASENT.


Jessica K. Smith,
Executive Director
Caroline G. Foote,
Director of Operations